FDA Imposes Clinical Hold on Biohaven’s Epilepsy Drug Opakalim, Weeks After $795 Million Licensing Deal
admin The U.S. Food and Drug Administration (FDA) has placed a clinical hold on the RISE-2...
admin
John Polson Appointed to CureSearch Board of Directors to Strengthen Strategic Leadership in Pediatric Cancer Research
CureSearch for Children’s Cancer, a leading national non-profit organization dedicated to accelerating the development of...
Biotech’s Reverse Merger Renaissance: From Last Resort to Wall Street Fast Track
In the sophisticated boardrooms of law firms and the bustling trading floors of investment banks,...
Gold Ribbon Hero: Macon
The Clinical Discovery and Immediate Intervention The diagnosis of pediatric leukemia often arrives with little...
A Decade of Momentum Children’s Cancer Research Fund Marks 45 Years of Innovation and 64 Million Dollars in Strategic Investments
The arrival of September marks the annual observance of Childhood Cancer Awareness Month, a period...
CureSearch Awards 2025 Young Investigator Grant to Dr. John Prensner for Groundbreaking ATRT Pediatric Brain Cancer Research
The landscape of pediatric oncology is witnessing a significant shift toward precision medicine as CureSearch...
Safeguarding Your Skin: A Comprehensive Look at UV Radiation, Skin Cancer Prevention, and Immunotherapy Advances
July marks Ultraviolet (UV) Radiation Safety Awareness Month, a critical period for public health organizations...
FDA Secures Key Leadership with Permanent Appointments to CDER and CBER, Signaling Stability Amidst Prior Turmoil
After nearly two tumultuous years marked by significant turnover in its upper echelons, the U.S....
Ultimate Hike Movement Accelerates Funding for Pediatric Cancer Research Through Endurance Fundraising and Advocacy
The CureSearch Ultimate Hike has emerged as a cornerstone of the national effort to address...
Tyra Biosciences’ Dabogratinib Phase 2 Results Disappoint Wall Street, Yet Analysts See Path Forward in Non-Muscle Invasive Bladder Cancer
San Diego, CA – September 9, 2026 – Tyra Biosciences, a clinical-stage biotechnology company, saw...
